Home > Inhibitors & Agonists > Tyrosine Kinase > Ephrin Receptor
Cat. No. Product name CAS No.
DC10209 ALW-II-41-27 Featured

ALW-II-41-27 is a novel Eph receptor tyrosine kinase inhibitor, used for cancer treatment.

1186206-79-0
DC7473 NVP-BHG712 Featured

NVP-BHG712 is a specific EphB4 inhibitor with ED50 of 25 nM that discriminates between VEGFR and EphB4 inhibition; also shows activity against c-Raf, c-Src and c-Abl with IC50 of 0.395 μM, 1.266 μM and 1.667 μM, respectively.

940310-85-0
DC11073 UniPR1331

UniPR1331 (UniPR-1331) is a selective, orally available antagonist of Eph/ephrin interaction with pIC50 of 5.45, IC50 of 2.9 uM.

1809170-59-9
DC50113 UniPR129

UniPR129 is a potent but problematic Eph/ephrin antagonist. UniPR129 has the potential for the research of cancer disease.

1639159-47-9
DC72101 BT5528

BT5528 is a bicyclic peptide toxin conjugate, an EphA2 activator. BT5528 is made up of a bicyclic peptide and Auristatin E (HY-15582), is derivated from BCY6099. BT5528 shows potent anti-tumor activity without bleeding or coagulation toxicity in rats model.

2648849-70-9
Page 1 / Total 1 FirstPrevNextLastGoto